A team of pharmaceutical researchers at Novartis Biomedical Research, working with an international team of associates, has ...

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 2Q25 FibroBiologics, Inc. (NASDAQ:FBLG) is continuing preparations for a Phase 1/2 trial ...

Research reveals how specific sleep stages protect brain vulnerable to Alzheimer's, offering hope through simple lifestyle ...

CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier ...

Spending lower proportions of time in two deep sleep stages — including REM sleep — may be linked to volume changes in ...

IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...

Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, has been selected by a major pharmaceutical company ...

Demolition works as part of preparations for the second phase of the Liverpool Health and Academic Precinct (LHAP) redevelopment of Liverpool Hospital will begin this month.

Tourmaline Bio's Pacibekitug shows promise in IL-6 targeting for autoimmune diseases. Learn about its potential and ongoing trials. Read why TRML is a hold.

The Histotripsy System generates microbubbles that rapidly expand and collapse, producing shock waves that break down tumours ...

Race Oncology has enabled patient enrolments at its first Aussie site for the Phase I trial of its cardioprotective ...

The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...